Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
‘Made in India – The story of Desh Bandhu Gupta, Lupin and Indian Pharma’ Book Launched in Mumbai
MUMBAI, India, Feb. 9, 2026 /PRNewswire/ -- Made in India, written by…
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
CORRECTING and REPLACING — BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 27, 2026 17:10 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for…
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong…
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
- Rapidly transforming into a leading global biopharma company January 09, 2026…
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
January 05, 2026 11:05 ET | Source: Zealand Pharma Press release –…
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
December 31, 2025 11:05 ET | Source: Zealand Pharma Company announcement –…
Alvotech announces European launch of first-in-market biosimilar to Simponi (golimumab) globally by partner Advanz Pharma
Introduction of AVT05 supported by NHS England tender award in the United…
